Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYTO -- Ignore unavailable to you. Want to Upgrade?

To: Mister E who wrote (7112)	3/30/1998 7:26:00 PM
From: Jody Ritchie	Read Replies (1) \| Respond to of 8116

The article sounds good, but I haven't seen it on Yahoo yet. Where did it come from? CYTO is mentioned in the article, but will CYTO's IR have a release for CYTO? Jody

To: Mister E who wrote (7112)	3/31/1998 12:21:00 AM
From: Webhead	Respond to of 8116

Unfortunately, the article doesn't come up with a "CYTO" ticker search so some may not notice it! I just wanted to refresh everyone's memory about the previous study of Quad in prostate and breast cancers that had spread to the bone. In addition to pain relief (further substantiated by the current article) QUAD led to an average of an additional year of life for breast cancer patients. So, not only is the quality of life improved by non-opiate pain relief but the patient lives an average of another year! I think that the current article is from the study designed to test Quad's theraputic value as well as pain relief and hopefully, more good news will be along (though not likely in the next few months). cytogen.com Ed